Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000902664-25-001113
Filing Date
2025-02-19
Accepted
2025-02-19 16:15:18
Documents
1
Period of Report
2025-02-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5892
  Complete submission text file 0000902664-25-001113.txt   8396
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address
Atchinson Robert (Reporting) CIK: 0001403404 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38360 | Film No.: 25640204

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address
Gross Phillip (Reporting) CIK: 0001403413 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38360 | Film No.: 25640203

Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 617-867-2800
Adage Capital Management, L.P. (Reporting) CIK: 0001535978 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38360 | Film No.: 25640205

Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Issuer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)